NRGene’s GenoMAGICTM Software Makes Genomic Selection and Trait Mapping More Efficient

Raleigh, North Carolina, & Ness Ziona, Israel – January 5, 2017 – Syngenta, a leading global agrochemical and seed company, has chosen NRGene’s GenoMAGICTM cloud-based software package for more comprehensive evaluations to accelerate trait discovery and breeding across diverse crops. NRGene is the leading genomic big data company.

“We were very pleased with our preliminary evaluations and are taking a more thorough look at the potential of GenoMAGIC in our research and development,” says Joseph Clarke, Principal Research Scientist, Syngenta. “The genetic diversity management strategies behind GenoMAGIC are a step above conventional means and enable clear value gains for downstream analytics, directly impacting cost and timeline models.”

The GenoMAGIC software analyzes unlimited volumes of genomic data, identifying broad sequence polymorphisms and haplotypes. This enables scientists and breeders to easily relate genomic sequences with beneficial traits, making genomic selection and trait mapping much more productive. Data use is accelerated, making breeding both faster and more cost effective. GenoMAGIC is being licensed non-exclusively to organizations involved in genetic research and breeding.

Syngenta continuously evaluates, develops and adopts cutting-edge technologies, like GenoMagic, to ensure the most relevant information is being used the right way to produce better performing seeds more cost effectively.

The Syngenta-NRGene two-year relationship has resulted in denovo assembly of multiple genomes across several crop species and creation of pangenomes that show strong potential to add value in breeding and genetic research. During 2016, Syngenta tested GenoMAGICTM by incorporating its own genetic diversity and field data to evaluate the benefits gained by GenoMAGIC analysis. Moving forward, the sophisticated genome management and data mining process behind GenoMagic will be evaluated more comprehensively at larger scale for broader value gains across the breeding process.

“The relationship between Syngenta and NRGene has already borne significant fruit,” says Dr. Gil Ronen, NRGene’s CEO. “Syngenta’s broad and diverse data cataloged within GenoMAGIC will continue to make breeding much more productive and efficient.”

About NRGene
NRGene is a genomic big data company developing cutting-edge software and algorithms to reveal the complexity and diversity of crop plants, animals, and aquatic organisms for the most advanced, sophisticated breeding. NRGene tools have already been employed by some of the world’s leading seed companies, as well as the most influential teams in academia. NRGene’s GenoMAGICTM and its DeNovoMAGICTM genome assembly solution continue to allow seed companies and major academic and research institutions around the world to support their research on maize, wheat, soybean, vegetables and other crops critical to support global food security.
www.nrgene.com

About Syngenta
Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter® at www.twitter.com/Syngenta

Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta’s publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract there for.

 

Media Contact
Amy Kenigsberg
K2 Global Communications
amy@k2-gc.com
+1-913-440-4072 (+7 ET)
+972-9-794-1681 (+2 GMT)